Mixing doses of the Oxford AstraZeneca and Pfizer BioNTech vaccines generates a robust immune response against coronavirus, research suggests.
Read More »Covid: Pfizer and AstraZeneca jabs effective against Indian variant – study
The Pfizer and AstraZeneca coronavirus vaccines are highly effective against the variant identified in India after two doses, a study has found.
Read More »EU takes legal action against AstraZeneca over covid vaccine delays
The European Union has launched legal action against pharmaceutical giant AstraZeneca over delivery shortfalls of its coronavirus vaccine, the European Commission said Monday.
Read More »People under 30 in UK to be offered alternative to AstraZeneca amid blood clot review
Britons aged 18-29 will be offered an alternative to the Oxford-AstraZeneca vaccine following 79 people developing blood clots after the jab, government advisors have decided.
Read More »AstraZeneca, Oxford vaccine up to 90% effective and easily transportable, says company
LONDON — The coronavirus vaccine developed by the University of Oxford and the British-Swedish pharmaceutical giant AstraZeneca is up to 90 percent effective when administered at a half dose and then a full booster dose a month later, scientists said Monday.
Read More »Leaked AstraZeneca report claims trial of experimental Covid-19 jab was briefly halted after woman, 37, suffered ‘transverse myelitis’
A leaked AstraZeneca report has claimed that the trial of one of the world’s most promising coronavirus jabs was briefly halted after a 37-year-old woman suffered a rare neurological condition that left her struggling to walk.
Read More »Oxford, AstraZeneca to resume Covid-19 vaccine trial after UK patient’s illness
Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.
Read More »Oxford University Covid vaccine trial put on hold due to adverse reaction in participant
The development of a promising Covid-19 vaccine has been put on hold due to an adverse reaction in a trial participant.
Read More »